Stock-Based Compensation (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount |
The Company recorded stock-based compensation on the Consolidated Statement of Operations for the three and six months ended June 30, 2026 and 2025 as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | Cost of revenue | | $ | 400 | | | $ | 302 | | | $ | 737 | | | $ | 718 | | | General and administrative | | 6,912 | | | 10,408 | | | 15,304 | | | 19,190 | | | Research and development | | 319 | | | 675 | | | 896 | | | 1,272 | | | Sales and marketing | | 585 | | | 830 | | | 915 | | | 1,788 | | | Total stock-based compensation | | $ | 8,216 | | | $ | 12,215 | | | $ | 17,852 | | | $ | 22,968 | |
|
| Schedule of Stock Option Activity |
six months ended June 30, 2026 is as follows: | | | | | | | | | | | | | | | | | Number of
Shares | | Weighted Average Exercise Price | | Outstanding at December 31, 2025 | | 7,162,201 | | | $ | 13.58 | | | Granted | | 3,113,058 | | | $ | 10.80 | | | | | | | | Exercised | | (141,782) | | | $ | 8.98 | | | Forfeited | | (993,759) | | | $ | 14.03 | | | Outstanding at June 30, 2026 | | 9,139,718 | | | $ | 12.65 | | | Vested and expected to vest at June 30, 2026 | | 9,139,718 | | | $ | 12.65 | | | Exercisable at June 30, 2026 | | 4,053,131 | | | $ | 14.40 | |
|
| Schedule of Fair Value of Each Stock Option Award Granted |
The fair value of each stock option award granted during the six months ended June 30, 2026 was estimated as of the grant date using a Black-Scholes model with the following assumptions: | | | | | | | | Six Months Ended
June 30, 2026 | | Expected term (in years) | 5.2 - 6.5 | | Risk-free interest rate (%) | 3.5% - 4.3% | | Expected volatility (%) | 62.4% - 68.2% | | Dividend yield (%) | — | | Weighted average grant date fair value per share | $6.20 |
|
| Schedule of Restricted Stock Activity |
A summary of the restricted stock activity under the Company’s plans for the six months ended June 30, 2026 is as follows: | | | | | | | | | | | | | | | | | Number of Restricted
Shares | | Weighted Average Grant Date Fair Value | | Nonvested at December 31, 2025 | | 2,829,597 | | | $ | 11.89 | | | Granted | | 1,997,714 | | | $ | 10.20 | | | Vested | | (1,346,114) | | | $ | 12.17 | | | Forfeited | | (356,302) | | | $ | 12.03 | | | Nonvested at June 30, 2026 | | 3,124,895 | | | $ | 10.67 | |
A summary of the PSU activity under the Company’s plans for the six months ended June 30, 2026 is as follows:
| | | | | | | | | | | | | | | | | Number of Stock Units | | Weighted Average Grant Date Fair Value | | Nonvested at December 31, 2025 | | 552,208 | | | $ | 19.38 | | | Granted | | — | | | $ | — | | | Vested | | — | | | $ | — | | | Forfeited | | (241,492) | | | $ | 21.82 | | | Nonvested at June 30, 2026 | | 310,716 | | | $ | 17.48 | |
|